These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18520169)

  • 21. House dust mites on skin, clothes, and bedding of atopic dermatitis patients.
    Teplitsky V; Mumcuoglu KY; Babai I; Dalal I; Cohen R; Tanay A
    Int J Dermatol; 2008 Aug; 47(8):790-5. PubMed ID: 18717857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal dosing of allergen immunotherapy: efficacy, safety, long-lasting effect.
    Senna G; Crivellaro MA; Bonadonna P; Dama AR; Schiappoli M; Passalaqua
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):386-92. PubMed ID: 14768524
    [No Abstract]   [Full Text] [Related]  

  • 23. Future perspectives in the treatment of atopic dermatitis.
    Katoh N
    J Dermatol; 2009 Jul; 36(7):367-76. PubMed ID: 19583684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergen specific immunotherapy for atopic dermatitis.
    Novak N
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):542-46. PubMed ID: 17989532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent findings in atopic dermatitis.
    O'Connor R; Hamburger RN
    West J Med; 1979 Oct; 131(4):314. PubMed ID: 388870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Desensitization in type I skin hypersensitivity. Neutralization method (Miller)--relation of its effect to the immediate allergic test].
    Gondoh A
    Nihon Hifuka Gakkai Zasshi; 1983 Sep; 93(10):1075-89. PubMed ID: 6663793
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific immunotherapy design questions.
    Moed H; de Bot C; van der Wouden JC
    Allergy; 2006 Jul; 61(7):896. PubMed ID: 16792592
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficacy of tranilast administration and specific hyposensitization therapy of atopic dermatitis].
    Gondo A; Saeki N; Yamamoto E; Hirabayashi T; Tokuda Y
    Arerugi; 1985 May; 34(5):310-9. PubMed ID: 2412532
    [No Abstract]   [Full Text] [Related]  

  • 30. Looking into the future of Trichuris suis therapy.
    Hepworth MR; Hamelmann E; Lucius R; Hartmann S
    J Allergy Clin Immunol; 2010 Mar; 125(3):767-8; author reply 768-9. PubMed ID: 20153034
    [No Abstract]   [Full Text] [Related]  

  • 31. Allergen-antibody complexes in the treatment of atopic dermatitis: preliminary results of a double-blind placebo-controlled study.
    Leroy BP; Boden G; Jacquemin MG; Lachapelle JM; Saint-Remy JM
    Acta Derm Venereol Suppl (Stockh); 1992; 176():129-31. PubMed ID: 1476025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [House dust mite allergy: myths and realities].
    Bouton C; Ducommun J
    Rev Med Suisse; 2009 Apr; 5(199):832-6. PubMed ID: 19441749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis.
    Zachariae H; Cramers M; Herlin T; Jensen J; Kragballe K; Ternowitz T; Thestrup-Pedersen K
    Acta Derm Venereol Suppl (Stockh); 1985; 114():48-54. PubMed ID: 3859167
    [No Abstract]   [Full Text] [Related]  

  • 34. [Status and indications for SLIT in comparison to SCIT].
    Wedi B
    Hautarzt; 2008 Jul; 59(7):537-43. PubMed ID: 18535812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MMW Drug Prize 2008 awarded. SQ allergens allow allergic patients to breathe deeply].
    Wepner U
    MMW Fortschr Med; 2008 Jun; 150(26-27):21. PubMed ID: 18681225
    [No Abstract]   [Full Text] [Related]  

  • 36. [Atopic dermatitis. Treatment with transfer factor. A controlled clinical trial].
    Valdés Sánchez AF; Fernández Ortega C; Gómez Echeverría AH; Gillama Niebla E; Lastra Alfonso G; López Saura P
    Rev Alerg; 1991; 38(6):158-62. PubMed ID: 1792483
    [No Abstract]   [Full Text] [Related]  

  • 37. ['Drops for allergy' in children: often applied, but not effective].
    Brand PL
    Ned Tijdschr Geneeskd; 2008 Feb; 152(5):241-2. PubMed ID: 18333536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Future of allergen-specific immunotherapy: better understanding of the mechanisms, novel treatments, and long-term cure.
    Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):xiii-xxii. PubMed ID: 16701138
    [No Abstract]   [Full Text] [Related]  

  • 39. House dust mite reduction in the management of atopic dermatitis. A critically appraised topic.
    Garritsen FM; ter Haar NM; Spuls PI
    Br J Dermatol; 2013 Apr; 168(4):688-91. PubMed ID: 23528056
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of allergen-specific immunotherapy for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials.
    Bae JM; Choi YY; Park CO; Chung KY; Lee KH
    J Allergy Clin Immunol; 2013 Jul; 132(1):110-7. PubMed ID: 23647790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.